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Abstract
Introduction: Subclinical atherosclerosis (SCA) measures in multiple arterial beds are heritable phenotypes that are
associated with increased incidence of cardiovascular disease. We conducted a genome-wide association study (GWAS)
for SCA measurements in the community-based Framingham Heart Study.
Methods: Over 100,000 single nucleotide polymorphisms (SNPs) were genotyped (Human 100K GeneChip, Affymetrix)
in 1345 subjects from 310 families. We calculated sex-specific age-adjusted and multivariable-adjusted residuals in
subjects tested for quantitative SCA phenotypes, including ankle-brachial index, coronary artery calcification and
abdominal aortic calcification using multi-detector computed tomography, and carotid intimal medial thickness (IMT)
using carotid ultrasonography. We evaluated associations of these phenotypes with 70,987 autosomal SNPs with minor
allele frequency ≥ 0.10, call rate ≥ 80%, and Hardy-Weinberg p-value ≥ 0.001 in samples ranging from 673 to 984 subjects,
using linear regression with generalized estimating equations (GEE) methodology and family-based association testing
(FBAT). Variance components LOD scores were also calculated.
Results: There was no association result meeting criteria for genome-wide significance, but our methods identified 11
SNPs with p < 10-5 by GEE and five SNPs with p < 10-5 by FBAT for multivariable-adjusted phenotypes. Among the
associated variants were SNPs in or near genes that may be considered candidates for further study, such as rs1376877
(GEE p < 0.000001, located in ABI2) for maximum internal carotid artery IMT and rs4814615 (FBAT p = 0.000003,
located in PCSK2) for maximum common carotid artery IMT. Modest significant associations were noted with various
SCA phenotypes for variants in previously reported atherosclerosis candidate genes, including NOS3  and  ESR1.
Associations were also noted of a region on chromosome 9p21 with CAC phenotypes that confirm associations with
coronary heart disease and CAC in two recently reported genome-wide association studies. In linkage analyses, several
regions of genome-wide linkage were noted, confirming previously reported linkage of internal carotid artery IMT on
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chromosome 12. All GEE, FBAT and linkage results are provided as an open-access results resource at http://
www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007.
Conclusion: The results from this GWAS generate hypotheses regarding several SNPs that may be associated with SCA
phenotypes in multiple arterial beds. Given the number of tests conducted, subsequent independent replication in a
staged approach is essential to identify genetic variants that may be implicated in atherosclerosis.
Background
Myocardial infarction, stroke and other atherosclerotic
cardiovascular diseases comprise the leading cause of
death for men and women in the U.S. [1], and will soon
become the leading cause of death worldwide [2]. Athero-
sclerosis in the arterial wall precedes the onset of most
cases of clinically apparent cardiovascular disease by dec-
ades, and subclinical atherosclerosis (SCA) is quite com-
mon in young and middle-aged persons [3-5]. SCA can be
detected and quantified in major arteries, such as the
carotid and coronary arteries, which provide essential
blood flow to major organs, using noninvasive, high res-
olution imaging modalities. Such measures include
peripheral arterial atherosclerosis detected by the ankle-
brachial index (ABI); internal and common carotid inti-
mal medial thickness (IMT) detected by B-mode ultra-
sound; and coronary artery calcium (CAC) and
abdominal aortic calcium (AAC) deposits by multidetec-
tor computed tomography (MDCT). We have previously
reported evidence for incomplete correlations between
carotid IMT, CAC and aortic calcium [6]. Both genetic and
environmental factors underlie interindividual variability
in SCA, and significant heritability has been found for
measures of SCA in the peripheral vasculature [7], carotid
arteries [8], aorta [9], and coronary arteries [10]. Further,
while there is evidence for partial correlation of major car-
diovascular risk factors with atherosclerosis, multiple SCA
measures, including ABI, carotid IMT, CAC, and AAC,
have been shown to predict future risks for cardiovascular
disease independent of risk factors [11-14].
While SCA measures are heritable, relatively little is
known regarding the role of genetic variants in the inter-
individual variability in these quantitative measures of
atherosclerosis. To date, results from candidate gene asso-
ciation studies for clinically apparent cardiovascular dis-
ease or subclinical disease have been inconsistent, though
overviews of multiple studies seem to provide evidence
for modest associations for variants in a number of candi-
date genes, such as APOE and ACE [8,15]. Genome-wide
association studies (GWAS) using densely spaced single
nucleotide polymorphisms (SNPs) provide a more com-
prehensive approach unconstrained by existing knowl-
edge to test common genetic variation across the genome
using high-throughput genotyping arrays. From GWAS,
several previously unrecognized genes have been identi-
fied that may contribute to disease, including CFH and
age-related macular degeneration [16], INSIG2 and obes-
ity [17], NOS1AP with QT interval variation [18], and sev-
eral genes including TCF7L2 [19] as well as IGF2BP2 and
CDKA1 with diabetes mellitus [20-22]. Additionally, two
other GWAS have identified an association with coronary
heart disease of SNPs in a region of chromosome 9p21
[23,24] that was also associated with diabetes mellitus in
three previous GWAS [20-22]. Of note, there was an asso-
ciation of this chromosome 9 region with the SCA meas-
ure of coronary artery calcium in one replication study
[19,24].
With the availability of high resolution imaging of athero-
sclerosis phenotypes in specific arterial beds in commu-
nity-based cohorts such as the Framingham Heart Study,
GWAS analysis is now possible for quantitative SCA phe-
notypes in major arterial beds. Recently, over 100,000 sin-
gle nucleotide polymorphisms (SNPs) were genotyped
(Human 100K GeneChip, Affymetrix) in 1,345 subjects
from 310 pedigrees in the Framingham Heart Study. The
primary objective of this report is to present a brief sum-
mary of the results of this GWAS for SCA detected in the
lower extremity arteries, carotid arteries, aorta and coro-
nary arteries, by conduct of genetic association analyses
and genetic linkage mapping. This report is one of a series
of manuscripts from a collaborative project conducted by
Framingham Heart Study investigators; the overall
approach to this project's statistical genetic methods is
summarized in an Overview manuscript that summarizes
the 100K genome-wide association study [25].
Materials and methods
Study sample
Participants from the Offspring Cohort of the Framing-
ham Heart Study who underwent one or more SCA meas-
urements and genotyping with the Affymetrix 100K
GeneChip are included in the study sample; genotyping
was completed in a total of 1,345 subjects (1,084 Off-
spring cohort subjects). Original cohort subjects did not
undergo the recently conducted MDCT or carotid IMT
testing and as such were not included in this study. Of the
1,084 Offspring cohort subjects with genotyping, up to
984 participants with SCA phenotype information were
analyzed. Details regarding selection of participants and
genotyping are provided in the Overview [25].BMC Medical Genetics 2007, 8(Suppl 1):S4 http://www.biomedcentral.com/1471-2350/8/S1/S4
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Phenotype definitions & methods
Determination of the clinical characteristics in Offspring
participants reported here was obtained at study entry
(baseline) and at each follow-up examination, including
Offspring examinations 6 and 7. The methods of measure-
ment of the covariates (blood pressure, body height and
weight, lipids, diabetes mellitus, smoking and other clini-
cal characteristics) used in these analyses have been previ-
ously described [26]. For imaging tests conducted
between two examination cycles, covariates used in the
analysis were obtained from the earlier examination cycle.
Carotid ultrasonography for carotid IMT
Participants underwent carotid ultrasonography accord-
ing to a previously reported standardized protocol at Off-
spring examination 6 (1995 to 1998) [27]. Imaging was
conducted with a Toshiba SSH-140A imaging unit using a
high resolution 7.5 MHz transducer for the common
carotid artery, and a 5.0 MHz transducer for the internal
carotid artery. Images were gated to an electrocardiogram;
end-diastolic images were acquired. As previously
described, correlation coefficients for the mean and max-
imum internal carotid artery were 0.83 and 0.84, respec-
tively, based upon 25 readings by two separate readers
[28].
All studies were recorded on optical disk and read accord-
ing to a standardized protocol [29]. To quantify the degree
of thickening of the carotid artery walls, the measures of
IMT were summarized into two variables: one for com-
mon carotid artery and one for internal carotid artery.
Mean and maximum wall thicknesses of the common and
internal carotid artery were defined as the mean of the
wall thickness or the mean of the maximum wall thick-
ness for the near and far wall on the left and right sides.
The number of available measurements for averaging
ranged from 1–4 for the common carotid artery, and 1–8
for the internal carotid artery.
MDCT for CAC and AAC
Measures of CAC and AAC were obtained between 2002
and 2005 in Offspring participants, between examina-
tions 7 and 8. All eligible participants were imaged with
an eight-slice multidetector computed tomography
(Lightspeed Ultra, GE, Milwaukee, WI, USA) of the chest,
as previously described [30], as well as the abdomen. Each
subject underwent two chest CT scans and one abdominal
scan that were performed using a sequential scan protocol
with a slice collimation of 8 mm × 2.5 mm (120 KVp,
320/400 mA for .220 lbs body weight, respectively) dur-
ing a single end-inspiratory breath hold (typical duration
18 s). Image acquisition (330 ms) was prospectively initi-
ated at 50% of the cardiac cycle. For the abdominal scan,
thirty contiguous 5 mm thick slices of the abdomen were
acquired covering 150 mm above the level of S1. A cali-
bration phantom (Image Analysis, Lexington, KY, USA)
that contained rods of water and 75 and 150 mg/cm3 cal-
cium hydroxyapatite, was placed underneath each subject.
Calcium measurements were performed on an offline
workstation (Acquarius, Terarecon, San Matteo, CA, USA)
by a trained technician. Scoring of coronary calcification
has been previously described, and we reported excellent
intra and inter reader reproducibility for the CAC meas-
urements [30]. A calcified lesion in either the coronary
arteries or in the aorta was defined as an area of at least
three connected pixels with CT attenuation >130 Houns-
field Units using 3D connectivity criteria. A score for AAC
(for the abdominal scan) and CAC (for each of the two
chest scans) was calculated by multiplying the area of a
calcified lesion with a weighted CT attenuation score
dependent on the maximal CT attenuation (Hounsfield
Units) within a lesion. In modification to the original
Agatston Score that was originally developed for electron
beam CT, we applied this algorithm to our MDCT scan
protocol to score for CAC, as used in numerous previous
studies [30], as well as for AAC.
Ankle brachial index (ABI) for peripheral arterial disease
Ankle-brachial systolic blood pressure measurements
were obtained at Offspring examinations 6 and 7 accord-
ing to a standard protocol by trained technicians, as previ-
ously described [7]. Participants rested for a minimum of
five minutes in the supine position on the examining
table prior to blood pressure measurement. Blood pres-
sure cuffs were applied to bare ankles with the midpoint
of the bladder over the posterior tibial artery approxi-
mately three centimeters above the medial malleolus.
Systolic blood pressure was measured using an 8 mega-
hertz Doppler pen probe and an ultrasonic Doppler flow
detector (Parks Medical Electronics, Inc.). For each limb,
(right and left arms, right and left ankles) the cuff was
inflated quickly to the maximal inflation level and
deflated at a rate of 2 mmHg per second until the systolic
blood pressure became audible. All limb blood pressures
were repeated in reverse order. If the initial and repeat
blood pressures differed by more than 10 mmHg at any
one site, a third measurement was taken. Measurement
was taken from the dorsalis pedis artery only if the poste-
rior tibial pulse could not be located by palpation or with
the Doppler probe [7].
The ABI is defined as the ratio of the average systolic blood
pressure in the ankle divided by the average systolic blood
pressure in the arm. The higher arm mean was used to cal-
culate the ankle-brachial index for each leg. The lower of
the two ankle-brachial index measurements was used for
analysis.BMC Medical Genetics 2007, 8(Suppl 1):S4 http://www.biomedcentral.com/1471-2350/8/S1/S4
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Genotyping methods
Details of the genotyping methods are available in the
Overview [25]. Briefly, 112,990 SNPs on the Affymetrix
100K chip were genotyped using DNA from family mem-
bers of the Framingham Heart Study. For this report, SNPs
were excluded for the following reasons: minor allele fre-
quency ≤10% (n = 38,062); genotypic call rate ≤80% (n =
2346); Hardy Weinberg Equilibrium p-value ≤ 0.001(n =
1,595), leaving 70,987 SNPs available for analysis [25].
Results for all SNPs are reported on the open-access results
website.
Statistical analysis methods
In total, of the 1,084 Offspring cohort subjects with geno-
typing, 673 to 984 participants with analyzable pheno-
type information were available for analysis. Residuals
were created from multiple linear regression models in all
subjects with the SCA measures, regardless of whether
they were genotyped or not, to adjust phenotypes for cov-
ariates; these residuals were created in women and men
separately. Covariate adjustment for blood pressure and/
or hypertension was performed is several different ways.
For ABI, a dichotomous measure for hypertension (systo-
lic blood pressure > 140 or diastolic blood pressure > 90
or on treatment) was used. For CAC and AAC, systolic
blood pressure and use of anti-hypertensive treatment
were used as covariates. For carotid IMT, treatment-
adjusted systolic blood pressure was used. As previously
described, systolic blood pressures for those on treatment
are imputed to estimate what these values would be if the
subject were not on treatment [31]. Ranked normalized
deviates, created from the standardized residuals from the
regression models, were used in the genetic analyses. For
each sex, SCA phenotypes were age-adjusted and multi-
variable-adjusted; details of the covariates included in the
multivariable adjustment for each phenotype are pre-
sented in Table 1.
All association analyses were performed using either gen-
eralized estimating equations (GEE) or family-based asso-
ciation testing (FBAT). We evaluated associations of the
SCA phenotypes using an additive genetic model with
70,987 SNPs meeting criteria above. Details regarding
these analytic methods are provided in the Overview [25].
Only results of multivariable-adjusted SCA phenotypes
are displayed in Table 2. Linkage analysis was performed
using variance components methods on a subset of the
100K chip SNPs in linkage equilibrium and Marshfield
STR markers that were previously obtained [25].
We further sought to identify SNPs with consistent associ-
ations with phenotypes within measurement groups
using GEE and FBAT analyses. SNPs were selected based
on associations with multiple correlated traits in both
population- and family-based tests. We evaluated the fol-
lowing five phenotypic subgroups using sex-specific age-
adjusted and multivariable-adjusted residuals (Table 1):
ABI, common carotid artery IMT, internal carotid artery
IMT, AAC, and CAC. For each SNP we calculated the pro-
portion of phenotypes significantly associated with the
SNP with P < 0.01 in both GEE and FBAT. For instance, for
ABI, we evaluated GEE and FBAT results for both age-sex-
adjusted and multivariable-adjusted measures of ankle-
brachial index from both examination cycle 6 and 7 (in
Table 1, these variables are named RANKLEBI6,
RANKLEBI6MV, RANKLEBI7, and RANKLEBI7MV).
Results are displayed in Table 3 of the top 5 SNPs with the
highest proportions of significantly (P < 0.01) associated
phenotypes. For identical proportions of significant phe-
notypes, SNPs were additionally ranked by the logarithm
of the mean of GEE p-values.
Results
Ten SCA atherosclerosis measures were studied (Table 1).
For each SCA measurement, sex-specific, age-adjusted
phenotypes as well as age- and multivariable-adjusted
phenotypes were evaluated. Measures for ABI and carotid
IMT phenotypes were available in 880–984 participants,
whereas measures for MDCT phenotypes were available in
673–680 participants.
Tables 2a, 2b and 2c provides a summary of the most sig-
nificant findings in GEE, FBAT and linkage analyses,
respectively, across a number of selected multivariable-
adjusted phenotypes described in Table 1. Full-disclosure
of all results for all associations can be found at http://
www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/
study.cgi?id=phs000007. The top 25 most statistically sig-
nificant associated SNPs in GEE analyses are presented in
Table 2a. There were 11 SNPs with p < 10-5 in GEE analy-
ses. The top three associated SNPs are rs1376877 (p <
1*10-6, located in ABI2) associated with maximum inter-
nal carotid IMT, rs2390582 (p = 1*10-6, not located near
a known gene) associated with maximum CAC score, and
rs3849150 (p = 2*10-6, located near LRRC18) associated
with AAC score. The top 25 most significantly associated
SNPs in FBAT analyses are shown in Table 2b. There were
5 SNPs with p < 10-5 by FBAT. The top three associated
SNPs by FBAT are rs4814615 (p = 3*10-6, located in
PCSK2) associated with maximum common carotid IMT,
rs6053733 (p = 4*10-6, located near FLJ25067) associated
with mean common carotid IMT, and rs10499903 (p =
4*10-6, located near PFTK1) associated with ABI.
When we examined below the top 25 associations on our
list of nominally significant GEE results for various SCA
phenotypes, there were significant associations with mul-
tivariable-adjusted CAC for several SNPs on chromosome
9, including three SNPs (rs10511701, rs1556516 and
rs1537371; p-values for association 1.1 × 10-4, 8.8 × 10-5,BMC Medical Genetics 2007, 8(Suppl 1):S4 http://www.biomedcentral.com/1471-2350/8/S1/S4
Page 5 of 12
(page number not for citation purposes)
and 1.7 × 10-4, respectively) lying within a 15 kB region
implicated in recent GWAS's for coronary heart disease.
Similar associations were noted for age-and sex-adjusted
residuals for CAC.
Results for all multipoint LOD scores > 2.0 are displayed
in Table 2c. There were four LOD score results exceeding
3.0 and ten additional LOD score results exceeding 2.0.
Results for linkage of internal carotid artery IMT pheno-
types to chromosome 12 and 1 (the top three LOD score
results) and for chromosome 11 are consistent with find-
ings from our previous report [32]. Upon further inspec-
tion of the list of associations with p < 0.01 for each of the
phenotypes, SNPs in or near biologically plausible genes
were noted, including: fibroblast growth factor (FGF1) for
AAC, adrenergic, beta-2-, receptor (ADRB2) for CAC,
myocyte enhancer factor 2C (MEF2C) and thrombospon-
din 2 (THBS2) for common carotid artery IMT, and cAMP-
specific phosphodiesterase 4D (PDE4D) for ankle bra-
chial index.
In Table 3, we provide a summary of the top five associ-
ated SNPs for each of four phenotypic categories – ABI,
common carotid artery IMT, internal carotid artery IMT,
and CAC. SNPs were rank ordered first according to per-
cent of phenotypes with p < 0.01 for GEE and FBAT asso-
ciations and second by geometric mean of GEE p-values.
A number of SNPs were common to the top 25 associated
SNPs by GEE or FBAT reported in Tables 2a and 2b,
respectively, including rs28207 and rs4814615 for com-
mon carotid IMT and rs10483853 and rs10507130 for
CAC.
We further examined associations with SNPs in or near
regions of 37 candidate genes previously reported to have
been associated with SCA or overt coronary heart disease.
Table 1: Phenotype distribution, examination cycle, and numbers of participants with subclinical atherosclerosis phenotypes
Subclinical atherosclerosis 
measure
Phenotype Variable name N Offspring, exam Covariate adjustment
Ankle-brachial index RANKLEBI6 984 Offspring, 6 Age, sex-specific
RANKLEBI6MV 984 Offspring, 6 Age, smoking, diabetes, hypertension, total cholesterol/HDL ratio, log 
triglyceride, sex-specific
RANKLEBI7 982 Offspring, 7 Age, sex-specific
RANKLEBI7MV 982 Offspring, 7 Age, smoking, diabetes, hypertension, total cholesterol/HDL ratio, log 
triglyceride, sex-specific
Maximum carotid artery bulb IMT RNKCAROTBULBAS6 959 Offspring, 6 Age, sex-specific
RNKCAROTBULBMV6 951 Offspring, 6 Age, treatment-adjusted systolic blood pressure, BMI, cigarettes per 
day, HDL cholesterol, total cholesterol, diabetes, log triglyceride, and 
in women, menopausal status, hormone therapy, sex-specific
Maximum common carotid artery 
IMT
RNKCAROTCCAMAXAS6 978 Offspring, 6 Age, sex-specific
RNKCAROTCCAMAXMV6 969 Offspring, 6 Age, treatment-adjusted systolic blood pressure, BMI, cigarettes per 
day, HDL cholesterol, total cholesterol, diabetes, log triglyceride, and 
in women, menopausal status, hormone therapy, sex-specific
Mean common carotid artery IMT RNKCAROTCCAMEANAS6 978 Offspring, 6 Age, sex-specific
RNKCAROTCCAMEANMV6 969 Offspring, 6 Age, treatment-adjusted systolic blood pressure, BMI, cigarettes per 
day, HDL cholesterol, total cholesterol, diabetes, log triglyceride, and 
in women, menopausal status, hormone therapy, sex-specific
Maximum internal carotid artery IMT RNKCAROTICAMAXAS6 888 Offspring, 6 Age, sex-specific
RNKCAROTICAMAXMV6 880 Offspring, 6 Age, treatment-adjusted systolic blood pressure, BMI, cigarettes per 
day, HDL cholesterol, total cholesterol, diabetes, log triglyceride, and 
in women, menopausal status, hormone therapy, sex-specific
Mean internal carotid artery IMT RNKCAROTICAMEANAS6 888 Offspring, 6 Age, sex-specific
RNKCAROTICAMEANMV6 880 Offspring, 6 Age, treatment-adjusted systolic blood pressure, BMI, cigarettes per 
day, HDL cholesterol, total cholesterol, diabetes, log triglyceride, and 
in women, menopausal status, hormone therapy, sex-specific
Maximum carotid artery stenosis RNKCAROTSTENAS6 977 Offspring, 6 Age, sex-specific
RNKCAROTSTENMV6 968 Offspring, 6 Age, treatment-adjusted systolic blood pressure, BMI, cigarettes per 
day, HDL cholesterol, total cholesterol, diabetes, log triglycerides, 
menopausal status, hormone therapy, sex-specific
Mean abdominal aortic calcification RESMDCTAACAS7 675 Offspring, 7 Age, sex-specific
RESMDCTAACMV7 673 Offspring, 7 Age, BMI, current cigarette smoking status, diabetes, systolic blood 
pressure, anti-HTN therapy, total-to-HDL-C ratio, lipid therapy, sex-
specific
Mean coronary artery calcification RESMDCTCACAS7 680 Offspring, 7 Age, sex-specific
RESMDCTCACMV7 678 Offspring, 7 Age, BMI, current cigarette smoking status, Diabetes, systolic blood 
pressure, anti-HTN therapy, total-to-HDL cholesterol ratio, lipid 
therapy, sex-specific
Maximum coronary artery 
calcification
RESMDCTCACMAXAS7 680 Offspring, 7 Age, sex-specific
RESMDCTCACMAXMV7 678 Offspring, 7 Age, BMI, current cigarette smoking status, diabetes, systolic blood 
pressure, anti-HTN therapy, total-to-HDL cholesterol ratio, lipid 
therapy, sex-specific
Abbreviations: IMT = intimal medial thickness; MDCT = multidetector Computed Tomography; AAC = abdominal aortic calcification; CAC = coronary artery calcification; 
HDL = high density lipoprotein; BMI = body mass index; anti-HTN therapy = drug treatment for hypertension; lipid therapy = drug treatment for hyperlipidemia.BMC Medical Genetics 2007, 8(Suppl 1):S4 http://www.biomedcentral.com/1471-2350/8/S1/S4
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Table 2: 25 Most significant results for multivariable-adjusted subclinical atherosclerosis measures in multiple arterial territories by 
GEE (2a), FBAT (2b) and linkage (2c) analyses
2a. Most significant results for GEE analyses for multivariable-adjusted subclinical atherosclerosis measures
GEE rank Phenotype SNP Chr Physical location GEE P-value FBAT P-value Gene position Gene symbol
1 Internal carotid artery IMT rs1376877 2 204,097,596 3.8 × 10-7 0.15 IN ABI2
3 Coronary artery calcification rs2390582 1 90,655,928 1.4 × 10-6 0.34 OUT
4 Abdominal aortic calcification rs3849150 10 49,779,229 1.6 × 10-6 4.0 × 10-3 NEAR LRRC18
6 Ankle brachial index rs2896103 5 13,817,419 4.5 × 10-6 0.01 IN DNAH5
7 Coronary artery calcification rs10483853 14 72,826,052 6.1 × 10-6 1.7 × 10-3 IN NUMB
8 Common carotid artery IMT rs1400544 1 186,593,061 6.2 × 10-6 4.7 × 10-4 OUT
9 Ankle brachial index rs7715811 5 13,822,974 6.4 × 10-6 0.02 IN DNAH5
10 Coronary artery calcification rs10507130 12 100,256,422 6.7 × 10-6 1.6 × 10-3 IN DRIM
11 Ankle brachial index rs1320267 4 127,290,897 6.9 × 10-6 0.03 OUT
13 Ankle brachial index rs1350445 11 91,591,802 8.5 × 10-6 0.07 OUT
14 Ankle brachial index rs1502050 5 13,832,743 8.7 × 10-6 0.02 IN DNAH5
15 Coronary artery calcification rs10519394 4 137,962,214 1.1 × 10-5 0.03 OUT
16 Internal carotid artery IMT rs683366 18 52,370,975 1.2 × 10-5 0.01 NEAR TXNL1
19 Abdominal aortic calcification rs2850711 18 59,938,018 1.5 × 10-5 0.05 IN C18orf20
20 Internal carotid artery IMT rs601746 10 96,932,273 1.6 × 10-5 0.22 NEAR C10orf129
21 Ankle brachial index rs1905155 5 113,301,097 1.6 × 10-5 5.1 × 10-3 OUT
22 Ankle brachial index rs10501784 11 91,592,192 1.6 × 10-5 0.30 OUT
23 Ankle brachial index rs10493529 1 74,335,469 1.9 × 10-5 0.098 NEAR LRRC44, FPGT
24 Common carotid artery IMT rs28207 5 13,267,852 1.9 × 10-5 2.1 × 10-4 OUT
25 Abdominal aortic calcification rs8094641 18 59,873,880 2.0 × 10-5 0.04 NEAR C18orf20
26 Ankle brachial index rs2949535 18 26,111,783 2.0 × 10-5 7.5 × 10-4 OUT
27 Coronary artery calcification rs2270861 12 100,238,849 2.0 × 10-5 6.8 × 10-3 IN DRIM
28 Common carotid artery IMT rs853406 6 4,002,159 2.2 × 10-5 1.9 × 10-3 IN PRPF4B
29 Common carotid artery IMT rs853407 6 4,002,232 2.2 × 10-5 2.5 × 10-3 IN PRPF4B
30 Common carotid artery IMT rs1581413 3 158,532,867 2.2 × 10-5 1.8 × 10-3 IN VEPH1
2b. Most significant results for FBAT analyses for multivariable-adjusted subclinical atherosclerosis measures
FBAT 
rank
Phenotype SNP Chr Physical location GEE P-value FBAT P-value Gene position Gene symbol
1 Common carotid artery IMT rs4814615 20 17,305,573 4.9 × 10-5 3.4 × 10-6 IN PCSK2
2 Common carotid artery IMT rs6053733 20 5,763,074 7.2 × 10-3 3.7 × 10-6 IN C20orf196
3 Ankle brachial index rs10499903 7 90,504,268 1.9 × 10-3 4.1 × 10-6 NEAR PFTK1, FZD1
4 Ankle brachial index rs9302997 17 71,723,439 4.8 × 10-3 5.1 × 10-6 IN RNF157
5 Ankle brachial index rs590183 4 23,733,535 0.01 8.6 × 10-6 OUT
7 Ankle brachial index rs6832344 4 23,733,805 9.9 × 10-3 1.0 × 10-5 OUT
8 Abdominal aortic calcification rs1023568 2 191,340,948 0.09 1.2 × 10-5 IN NAB1
9 Common carotid artery IMT rs2214959 12 124,674,521 0.01 1.5 × 10-5 NEAR TMEM132BBMC Medical Genetics 2007, 8(Suppl 1):S4 http://www.biomedcentral.com/1471-2350/8/S1/S4
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10 Ankle brachial index rs9285151 13 42,712,236 0.06 1.7 × 10-5 IN ENOX1
11 Ankle brachial index rs1381632 4 88,926,163 0.36 1.8 × 10-5 NEAR DMP1
12 Coronary artery calcification rs4461066 16 51,469,110 8.7 × 10-3 3.1 × 10-5 OUT
15 Coronary artery calcification rs367421 20 15,202,689 2.5 × 10-3 3.6 × 10-5 IN C20orf133
16 Internal carotid artery IMT rs9323431 14 62,638,241 0.24 3.6 × 10-5 IN KCNH5
17 Common carotid artery IMT rs1997463 3 54,782,280 0.01 3.8 × 10-5 IN CACNA2D3
19 Common carotid artery IMT rs304409 18 1,096,342 1.8 × 10-4 4.6 × 10-5 OUT
21 Internal carotid artery IMT rs1349008 3 76,804,103 0.23 4.9 × 10-5 OUT
22 Ankle brachial index rs2251671 8 40,501,973 1.3 × 10-4 4.9 × 10-5 NEAR ZMAT4
23 Abdominal aortic calcification rs243030 2 60,518,222 3.1 × 10-5 5.6 × 10-5 OUT
24 Abdominal aortic calcification rs321967 7 77,959,200 4.7 × 10-4 6.0 × 10-5 IN MAGI2
25 Ankle brachial index rs6569792 6 132,736,444 0.56 6.4 × 10-5 IN MOXD1
26 Abdominal aortic calcification rs4985741 17 17,028,605 7.2 × 10-3 6.6 × 10-5 IN MRIP
27 Ankle brachial index rs7995026 13 42,751,550 6.9 × 10-4 6.9 × 10-5 IN ENOX1
28 Coronary artery calcification rs10520541 4 184,055,754 0.08 7.0 × 10-5 IN AK001336
29 Internal carotid artery IMT rs2113945 15 29,111,823 0.09 7.2 × 10-5 IN TRPM1
30 Common carotid artery IMT rs6944400 7 131,389,740 0.12 8.2 × 10-5 OUT
2c. Genomic regions with LOD > 2.0 for linkage analyses for multivariable-adjusted subclinical atherosclerosis measures
Rank Phenotype Marker Chr Physical location LOD score 1.5 interval bounds Maximum 
LOD
1 Internal carotid artery IMT ATA29A06 12 128,922,618 127,583,749 129,277,512 5.05
2 Internal carotid artery IMT rs959987 12 127,817,680 126,600,362 129,277,512 4.78
3 Internal carotid artery IMT rs1180937 1 54,903,665 45,417,474 56,950,040 4.23
8 Abdominal aortic calcification rs17030524 12 99,640,364 97,320,770 102,339,523 3.51
6 Coronary artery calcification SNP_A-
1679277
6 149,300,408 136,476,887 154,228,170 2.81
7 Ankle brachial index rs394884 2 151,954,268 142,801,622 168,477,710 2.73
9 Internal carotid artery IMT rs300574 4 124,681,343 118,755,997 131,657,093 2.49
10 Internal carotid artery IMT rs714647 15 99,870,157 96,719,695 100,152,332 2.49
12 Coronary artery calcification rs1106679 14 102,555,405 91,636,556 106,312,036 2.33
13 Abdominal aortic calcification rs1454183 2 13,935,308 3,238,478 20,119,479 2.31
15 Coronary artery calcification rs7000744 8 140,003,669 136,360,837 146,039,126 2.23
16 Ankle brachial index rs10483084 21 42,268,393 40,113,290 45,025,009 2.12
17 Internal carotid artery IMT rs1948685 5 21,064,843 10,288,046 31,560,322 2.11
19 Internal carotid artery IMT rs10832008 11 13,232,905 6,384,682 19,637,706 2.09
Abbreviations: SNP = single nucleotide polymorphism; Chr = chromosome; GEE = generalized estimating equations; FBAT = family based association testing; LOD = 
logarithm of the odds; IMT = intimal medial thickness;. Gaps appear in the rank order for markers that appear more than once. In the column entitled “Phenotype”, 'internal 
carotid artery IMT' denotes either mean or maximum internal carotid IMT, 'common carotid artery IMT' denotes either mean or maximum common carotid IMT, 'coronary 
artery calcification' denotes either mean CAC or max CAC, and 'ankle brachial index' denotes and ankle brachial index from either examination cycle 6 or cycle 7. For 
proximity to known genes (Table columns nine and ten), “IN” refers to a SNP within a protein-coding gene intron or exon, “OUT” refers to a SNP greater than 60 kb away 
from a protein-coding gene gene, and “NEAR” refer to a SNP within 60 kb of a protein-coding gene.
Table 2: 25 Most significant results for multivariable-adjusted subclinical atherosclerosis measures in multiple arterial territories by 
GEE (2a), FBAT (2b) and linkage (2c) analyses (Continued)BMC Medical Genetics 2007, 8(Suppl 1):S4 http://www.biomedcentral.com/1471-2350/8/S1/S4
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Of these genes, there were 28 genes with SNPs on the
100K array that were in or nearby (within 60 kb of) the
gene. In Table 4, we report significant associations for
SNPs in or near nine of these 28 candidate genes with p <
0.01 in GEE or FBAT analyses or p < 0.05 in both GEE and
FBAT analyses. Associations were noted with one or more
SCA measure for: CCR5,  FGB,  ESR1,  IL6,  NOS3,
TNFRSF11, ADM, CD44, and CCL2 (Table 4).
Discussion
In this manuscript, we report the principle findings for a
GWAS of SNPs from a 100K Affymetrix scan with SCA
phenotypes in multiple major arterial beds. A conserva-
tive Bonferroni correction using this number of tests
(0.05/1,000,000) would yield an approximate threshold
of genome-wide significance to be 5*10-8, and none of
our association findings meet these criteria for genome-
wide association., However, we did note a number of
associations with p < 10-5 after rank-ordering SNP associ-
ations using GEE and/or FBAT analysis. While we expect
that many of these genotype-phenotype associations may
be false positives, the SNPs identified in this manner are
nonetheless hypothesized to include SNPs that merit fur-
ther follow-up. To our knowledge, this is the first report of
a GWAS using SCA phenotypes.
The first replicated GWAS findings for clinically apparent
coronary heart disease were recently reported by two inde-
pendent groups, identifying an association with SNPs in a
region of chromosome 9p21 [23,24]. Interestingly, there
was an association of this chromosome 9 region with CAC
in one replication study [24], and this same chromosome
9 region was associated with diabetes mellitus in three
other recent GWAS [20-22]. When we examined our GEE
results for various SCA phenotypes, there were nominally
significant associations with multivariable-adjusted CAC
for several SNPs on chromosome 9 lying within a 15 kB
region implicated in the recent GWAS's for coronary heart
disease. While these SNPs were not our top-ranked SNPs,
their specific association with coronary artery atheroscle-
rosis (CAC) phenotypes likely represent strong evidence
of replication in light of the recent GWAS.
Table 3: Five most significant association results using FBAT and GEE within phenotype clusters for each of five multivariable-adjusted 
subclinical atherosclerosis measures
Phenotype group Rank GEE/FBAT SNP Chr Physical
location
%Phenotypes
P < 0.01 for
GEE & FBAT
GEE P-value 
geometric 
mean
MAF Gene position Gene symbol
Ankle brachial index 1 rs7989017 13 25,164,878 100 4.7 × 10-3 0.22 IN ATP8A2
2 rs7546903 1 6,870,538 75 1.7 × 10-3 0.27 IN CAMTA1
3 rs6135095 20 1,422,405 75 3.0 × 10-3 0.14 NEAR SIRPB2
4 rs1875517 3 118,790,257 75 3.4 × 10-3 0.44 OUT
5 rs6507763 18 43,310,669 75 3.5 × 10-3 0.14 OUT
Common carotid artery 
IMT
1 rs1039610 18 74,049,795 100 4.9 × 10-5 0.32 OUT
2 rs1587893 18 74,039,913 100 5.8 × 10-5 0.31 OUT
3 rs28207 5 13,267,852 100 8.1 × 10-5 0.37 OUT
4 rs4814615 20 17,305,573 100 1.3 × 10-4 0.16 IN PCSK2
5 rs2470209 17 28,263,442 100 1.9 × 10-4 0.39 NEAR MYO1D
Internal carotid artery 
IMT
1 rs933890 12 106,941,389 100 6.6 × 10-4 0.22 OUT
2 rs8075776 17 36,408,189 100 9.8 × 10-4 0.16 NEAR KRTAP1-1, KRTAP1-3
3 rs252984 5 106,780,236 100 1.0 × 10-3 0.16 IN EFNA5
4 rs10490889 3 6,257,028 100 1.6 × 10-3 0.36 OUT
5 rs10516308 4 16,780,451 100 3.3 × 10-3 0.41 OUT
Coronary artery 
calcification
1 rs10483853 14 72,826,052 100 9.8 × 10-6 0.19 IN NUMB
2 rs10507130 12 100,256,422 100 1.3 × 10-5 0.22 IN DRIM
3 rs9321354 6 132,946,880 100 3.4 × 10-5 0.12 NEAR TAAR8, TAAR6, TAAR5
4 rs220457 17 27,126,748 100 3.8 × 10-4 0.25 OUT
5 rs10505182 8 113,337,274 100 5.2 × 10-4 0.23 IN CSMD3
Abbreviations: SNP = single nucleotide polymorphism; Chr = chromosome; GEE = generalized estimating equations; FBAT = family based association testing; IMT = intimal 
medial thickness; MAF = minor allele frequency.
Column Definitions: For each Phenotype Group (Table column one), a cluster analysis is conducted for several phenotype variables defined in Table 1. For “Ankle brachial 
index,” GEE and FBAT results were evaluated for RANKLEBI6, RANKLEBI6MV, RANKLEBI7, and RANKLEBI7MV; for “Common carotid artery IMT,” 
RNKCAROTCCAMAXAS6, RNKCAROTCCAMAXMV6, RNKCAROTCCAMEANAS6, and RNKCAROTCCAMEANMV6; for “Internal carotid artery IMT,” 
RNKCAROTICAMAXAS6, RNKCAROTICAMAXMV6, RNKCAROTICAMEANAS6, and RNKCAROTICAMEANMV6; and for “Coronary artery calcification,” 
RESMDCTCACMAXMV7 and RESMDCTCACMV7. The percent of phenotypes in the cluster analysis for which there was a p < 0.01 by both GEE and FBAT analyses is 
shown in Table column five. The geometric mean p-value is shown in Table column six for GEE associations for all phenotypes in the cluster analyses. For proximity to known 
genes (Gene position, Table column eight), “IN” refers to a SNP within a protein-coding gene intron or exon, “OUT” refers to a SNP greater than 60 kb away from a protein-
coding gene gene, and “NEAR” refer to a SNP within 60 kb of a protein-coding gene.BMC Medical Genetics 2007, 8(Suppl 1):S4 http://www.biomedcentral.com/1471-2350/8/S1/S4
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Because there may be distinct genetic determination for
atherosclerosis occurring in individual vascular beds (e.g.,
carotid arteries versus coronary arteries versus aorta versus
peripheral arteries), we further examined for consistency
of association of specific SNPs within five trait groups –
ABI, common carotid artery IMT, internal carotid artery
IMT, AAC and CAC. By this method of ranking associa-
tions, we identified distinct sets of SNPs, for which there
was consistency of overlap with top SNP results by both
GEE and FBAT (Table 3). There is evidence for partial cor-
relation between SCA measures [6], and it is interesting to
note that there were some SNPs for which there were
nominally significant associations with more than one
SCA measure. For example, rs10263213 is associated with
both multivariable adjusted CAC (p = 0.001) and multi-
variable adjusted wall thickness of the carotid bulb (p =
0.013). Further research is warranted to determine
whether SNPs showing association with two or more SCA
measures are more likely to replicate in follow-up studies.
Again, because no results from these approaches met cri-
teria for genome-wide association, further validation
studies will be required to confirm such associations.
Table 4: SNPs in or near previously reported candidate genes for coronary heart disease or subclinical atherosclerosis for 
multivariable-adjusted SCA phenotypes: SNPs with p < 0.01 in GEE or FBAT analyses, or p < 0.05 in both GEE and FBAT analyses.
Chr Gene N SNPs within 60 kb SNP from Affy 100K Array MAF Physical Location Phenotype Lowest P-value
GEE FBAT
3 CCR5 1/6 rs3762823 0.25 46,371,620 Common carotid artery IMT 0.02 0.04
Common carotid artery IMT 0.05 0.04
4 FGB 1/7 rs871540 0.22 155,766,635 Abdominal aortic calcification 0.11 3.0 × 10-3
6 ESR1 8/18 rs3866461 0.12 152,238,835 Coronary artery calcification 5.4 × 10-3 0.11
Coronary artery calcification 3.4 × 10-3 0.12
rs3853250 0.45 152,252,014 Ankle brachial index 0.05 0.04
rs3853251 0.34 152,252,870 Ankle brachial index 0.03 0.02
rs722208 0.27 152,414,999 Coronary artery calcification 0.54 5.7 × 10-3
Coronary artery calcification 0.57 5.0 × 10-3
rs3798573 0.11 152,481,476 Internal carotid artery IMT 6.4 × 10-3 0.78
rs3778099 0.10 152,510,689 Common carotid artery IMT 0.82 6.9 × 10-3
rs2813563 0.19 152,538,601 Abdominal aortic calcification 0.02 0.03
rs725467 0.19 152,539,833 Abdominal aortic calcification 0.02 0.03
7 IL6 2/9 rs1581498 0.45 22,681,483 Coronary artery calcification 0.16 7.7 × 10-3
Coronary artery calcification 0.04 3.3 × 10-3
rs10240716 0.27 22,765,225 Ankle brachial index 0.01 0.04
7 NOS3 2/3 rs768403 0.38 150,297,894 Abdominal aortic calcification 2.0 × 10-3 0.02
rs7812088 0.12 150,357,477 Internal carotid artery IMT 0.05 5.5 × 10-3
Internal carotid artery IMT 0.05 0.01
8 TNFRSF11 1/9 rs10505346 0.21 120,033,024 Ankle brachial index 0.04 0.05
11 ADM 3/5 rs10500724 0.44 10,258,592 Ankle brachial index 2.0 × 10-4 5.0 × 10-4
rs4444073 0.47 10,288,240 Ankle brachial index 3.3 × 10-3 5.0 × 10-4
rs4444073 Ankle brachial index 0.01 0.04
11 CD44 10/24 rs1365057 0.22 35,066,251 Coronary artery calcification 0.05 8.9 × 10-3
Coronary artery calcification 0.05 7.7 × 10-3
rs353589 0.21 35,077,802 Ankle brachial index 9.0 × 10-3 0.08
Abdominal aortic calcification 7.4 × 10-3 0.10
rs353639 0.21 35,140,940 Ankle brachial index 8.3 × 10-3 0.03
Ankle brachial index 3.1 × 10-3 0.04
rs353638 0.21 35,141,103 Ankle brachial index 5.6 × 10-3 0.05
Ankle brachial index 4.2 × 10-3 0.06
rs353636 0.21 35,141,306 Ankle brachial index 7.6 × 10-3 0.05
Ankle brachial index 4.2 × 10-3 0.06
rs353635 0.46 35,141,399 Ankle brachial index 0.09 4.6 × 10-3
rs353631 0.20 35,144,144 Ankle brachial index 4.8 × 10-3 0.06
Ankle brachial index 4.5 × 10-3 0.15
rs1467558 0.21 35,186,249 Coronary artery calcification 0.03 0.02
Coronary artery calcification 0.03 0.02
rs10488813 0.13 35,225,530 Abdominal aortic calcification 8.8 × 10-3 0.48
rs7115246 0.46 35,243,054 Ankle brachial index 7.1 × 10-3 9.4 × 10-3
17 CCL2 1/7 rs1024612 0.41 29,573,469 Abdominal aortic calcification 3.6 × 10-3 0.22
Abbreviations: SNP = single nucleotide polymorphism; Chr = chromosome; GEE = generalized estimating equations; FBAT = family based association testing; IMT = intimal 
medial thickness; MAF = minor allele frequency.
Of 37 candidate genes considered, there were 28 genes covered by the 100K array and meeting exclusion criteria, of which nine genes had a significantly associated SNP(s) 
with either p < 0.01 for GEE, p < 0.01 for FBAT, or p < 0.05 for both GEE and FBAT. Genes without significant associations meeting these criteria included: F5, MTHFR, REN, 
APOB, CX3CR1, GATA2, EDN1, CTGF, VEGF, PON1, MMP3, SCARB1, ALOX5AP, CETP, ITGB3, NOS2A, APO3, and MMP9. However, it should be noted that 100K SNP coverage of 
any given gene region may be insufficient to exclude real associations. Better coverage may be afforded by newer, more dense SNP arrays. Only SNPs within the introns or 
exons of the candidate gene or no greater than 60 kb away from the candidate gene were considered for Table 4 (denominator of Column 3).BMC Medical Genetics 2007, 8(Suppl 1):S4 http://www.biomedcentral.com/1471-2350/8/S1/S4
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An extensive literature exists for prior studies of candidate
gene variation associated with clinical atherosclerotic car-
diovascular disease, in particular coronary heart disease
[15], as well as SCA, particularly carotid IMT [8]. While
many associations are not consistently noted from study
to study, a review of the available studies reveals a modest
overall association of clinical cardiovascular disease or
SCA with variants in candidate genes, such as APOE, ACE,
and NOS3 [15]. More recently, a number of screens of
larger numbers of variants have revealed new candidate
gene hypotheses, such as ALOX5AP [33,34] and LGALS2
[35]. When we examined for associations between SCA
and SNPs on the 100K chip that reside in or near some
previously studied candidate genes, we confirmed a
number of modestly significant SNP associations with
SCA phenotypes (Table 4). These and other associations
between SNPs and various SCA measures may be viewed
as supportive though not strongly confirmatory of prior
hypotheses. However, it should be noted that 100K SNP
coverage of any given gene region may be insufficient to
exclude real associations. Better coverage may be afforded
by newer, more dense SNP arrays. Nevertheless, these data
suggest that GWAS may be used to contribute substantial
information to the literature on the presence and strength
of previously reported "candidate gene" associations,
including those identified from other GWAS, as well as for
unbiased searches for novel variants.
Our study was conducted in a moderate-sized, well-char-
acterized community-based sample, and the conduct of
SCA imaging was conducted without ascertainment for
prior cardiovascular disease. Strengths and limitations of
the GWAS in this sample using a 100K screen are dis-
cussed in the Overview [25]. A strength of this particular
study is the substantial heritability of SCA phenotypes
determined by high resolution imaging conducted in a
reproducible manner. While these SCA phenotypes repre-
sent state of the art, non-invasive imaging in populations,
it must be acknowledged that the available modalities
allow a focus on only fixed anatomic components (e.g.,
calcific plaque or IMT) rather than dynamic or metaboli-
cally active components. Moreover, the occurrence and
distribution of these modalities may differ by race or envi-
ronmental background. Thus, our results may not extrap-
olate to non-white populations.
In conclusion, using a GWAS unconstrained by existing
knowledge, we have identified new candidate SNP associ-
ation hypotheses and further confirm some existing can-
didate gene and candidate SNP hypotheses. In particular,
the evidence for association of several SNPs with CAC in
the region of chromosome 9 that was recently reported to
be associated with CHD or CAC in tens of thousands of
subjects [23,24] provides evidence that we were able to
identify true associations. These findings provide evidence
for the exciting promise of GWAS of SCA to identify novel
genetic variants underlying atherosclerosis within specific
arterial territories or across multiple arterial territories. In
this manuscript and in the accompanying web-posted
results http://www.ncbi.nlm.nih.gov/projects/gap/cgi-
bin/study.cgi?id=phs000007., we provide a full disclosure
of the totality of our results, including all "non-signifi-
cant" associations. In light of the multiple association
tests that result from a GWAS, a powerful and efficient fol-
low-up approach to increase the statistical confidence for
an association of common variants with complex traits is
a staged design, in which a modest number of results from
the first stage are then tested in a second independent
sample and the combined statistical evidence considered
[36]. A further approach may be to seek evidence of in sil-
ico replication of our initial findings in other GWAS stud-
ies. The latter approach will be feasible with completion
of the planned dense GWAS (the NHLBI's SNP Health
Association [SHARe] Study) in over 9,000 men and
women from the Framingham Heart Study [37].
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